Category Archives: Uncategorized

15 Jun

2 Value Stocks to Dive Into Now: AK Steel Holding Corporation (AKS), Puma Biotechnology, Inc …

AK Steel Holding Corporation (NYSE:AKS) is simply too cheap to pass with a price-to-sales ratio of 0.24. The competitors from

14 Jun

Benchling Scores $14.5M to Grow Online Lab Notebook for Bio-Researchers

New immunotherapy approaches to cancer treatment, and the CRISPR technology for editing genetic material in cells, are among the most

14 Jun

Senator Hatch Calls Out IPR Flaws

During today’s Senate Judiciary hearing, Senator Orrin Hatch addressed the dysfunctional interplay of the inter partes review system with the

14 Jun

Call for proposals for action grants under 2017 Rights, Equality and Citizenship Work Programme

[Source: http://ec.europa.eu/health/ageing/innovation/index_en.htm] Identifier: REC-AG-2017Pillar: REC Programme 2014-2020Opening Date: Deadline: Tue, 7 Nov 2017 17:00:00 (Brussels local time)Modification Date: Thu, 14

13 Jun

Jayson Dallas Leaves Ultragenyx for CEO Post at Aimmune

Jayson Dallas has been appointed CEO of food allergy therapy developer Aimmune Therapeutics. Before joining Brisbane, CA-based Aimmune, Dallas was

13 Jun

Research Headlines – A meditative approach to active and healthy ageing

[Source: Research & Innovation] EU-funded research is exploring how meditation training and other preventive programmes can help Europe’s ageing society

13 Jun

Greenwood comment on PABNAB

BIO and BIO’s Board-level Workforce Development, Diversity and Inclusion (WDDI) Committee were disappointed that the planners of this year’s “Party

12 Jun

No Price Cuts Yet, But Azar Urges Congress to Target Drug Rebates & Transparency

Since President Trump announced his plan last month to lower prescription drug prices, a lot of rumors have been flying

12 Jun

European Innovation Council – Commission opens competition for a €10 million prize for low-cost space launch

[Source: Research & Innovation] The prize, run as part of the European Innovation Council (EIC) pilot funded under Horizon 2020,

11 Jun

Allergan’s Migraine-Reducing Pill Hits Study Goals, Heads to Phase 3

An experimental Allergan pill meant to help reduce the frequency of migraines met the main goals of a key study,